MOONLAKE IMMUNOTHERAPEUTICS
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-2.5M | $1.3M |
| FY2021 | — | $106.5K | $0 |
| FY2022 | — | $48.9M | $39.5M |
| FY2023 | — | $495.7M | $451.2M |
| FY2024 | $0 | $446.8M | $180.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-2.5M | $1.3M |
| FY2021 | — | $106.5K | $0 |
| FY2022 | — | $48.9M | $39.5M |
| FY2023 | — | $495.7M | $451.2M |
| FY2024 | $0 | $446.8M | $180.4M |